Mark Chadwick

Mark Chadwick is Chief Business Officer at FibroFind, responsible for leading commercial strategy and building partnerships with biopharma clients.

Mark brings more than 30 years of experience across biotech, CRO and platform technology companies. His background includes senior leadership and board-level roles across 12 ventures, including three that led to favourable exits, the most recent being the sale of Arcinova to Quotient Sciences.

Mark holds a PhD in Molecular Biology from Newcastle University and an MBA in Entrepreneurship from Imperial College London. He started his career as a Pfizer-sponsored Fellow in gene therapy at Corpus Christi College, Cambridge, working at the Laboratory of Molecular Biology, before joining his first biotech, Cambridge Genetics.